The global proton therapy systems market size is expected to reach USD 1.2 billion by 2030, growing at a CAGR of 7.3% from 2024 to 2030, according to a report by Grand View Research, Inc. The market is primarily driven by increasing number of proton therapy centers, rising number of cancer cases, and growing investments by hospitals to establish these centers.

Growing funds & investments by hospitals, manufacturers, and private investors are also contributing to the growth of this market. For instance, in August 2015, Mevion Medical Systems (U.S.) raised USD 200 million in an equity funding led by HOPU Investments (China) and YuanMing Capital (China). These funds are likely to be used for development of technologically advanced and low-cost products. Furthermore, governments across various geographies are including budgets for establishment of these centers. For instance, in July 2015, the state government of Victoria included nearly AUD 2 million (USD 1.53 million) to develop a National Centre for Proton Beam Therapy at the Victorian Comprehensive Cancer Centre (VCCC). The new center is expected to offer treatment to the patients in Australia.

Access the Proton Therapy Systems Market Size, Share & Trends Analysis Report By Product (Equipment, Services), By Type (Single-Room System, Multi-Room System), By Region, And Segment Forecasts, 2024 – 2030

In addition, rapid increase in the number of cancer cases globally is anticipated to bolster market growth during the forecast period. According to American Cancer Society, an estimated 1,688,780 new cancer cases are expected to be diagnosed in the U.S. and this disorder is likely to cause nearly 600,920 deaths in 2017. Furthermore, according to The Lancet, the number of women diagnosed with breast tumors is estimated to reach 3.2 million by 2030, which is almost double of 1.7 million in 2015.

Favorable reimbursement policies in the U.S and European countries and rising cancer-related healthcare expenditure in emerging nations is likely to propel the global proton therapy systems market. In addition, decreasing cost of proton therapy, increasing awareness, and rising adoption are expected to boost demand for these systems during the forecast period. However, high costs involved in the establishment of these centers and lack of reimbursement in emerging nations is likely to restrain growth in the coming years.

Proton Therapy Systems Market Report Highlights

·        The equipment segment held majority of the revenue share in 2023 due to rise in the number of contracts for establishment of proton therapy centers

·        The multi-room systems accounted for the largest market revenue share of 67.4% in 2030

·        North America proton therapy systems market dominated in 2023 and accounted for the market share of 42.7%.

·        Asia Pacific proton therapy systems market is estimated to register the fastest CAGR over the forecast period

Order your free sample copy of “Proton Therapy Systems Market Report 2024 - 2030, published by Grand View Research

Key Proton Therapy Systems Company Insights

Some key companies in the proton therapy systems market include IBA Worldwide, Optivus Proton Therapy, Inc., Hitachi, Ltd., and Sumitomo Heavy Industries, Ltd. Key companies are involved in strategic initiatives such as in innovating new products, collaborating with institutions and other industries, and establishing partnerships.

·        Hitachi Ltd. is a multinational company dedicated to manufacturing various electronic, communication, heavy electrical, and industrial machinery equipment. The company’s proton therapy systems provide cancer treatment using advanced technologies. The company has delivered proton therapy systems to hospitals such as the HKSH Medical Group, which are equipped with scanning technology.

·        Optivus Proton Therapy, Inc. provides healthcare services dedicated to the advancing proton therapy technology. The company offers proton therapy systems such as Conforma 3000, a sixth-generation proton beam technology, and Odessey, a treatment planning system now operating on the updated Odessey 5.0 updated version of the software.

Key Proton Therapy Systems Companies:

The following are the leading companies in the proton therapy systems market. These companies collectively hold the largest market share and dictate industry trends.

·        IBA Worldwide

·        Optivus Proton Therapy, Inc.

·        Mevion Medical Systems

·        Advanced Oncotherapy plc

·        Varian Medical Systems, Inc

·        ProTom International, Inc

·        Hitachi, Ltd.

·        Mitsubishi Corporation

·        ProNova Solutions, LLC

·        Sumitomo Heavy Industries, Ltd

Recent Developments

·        In January 2024, Israel-based P-cure company started building a proton therapy center to provide access to inexpensive treatment to Chinese cancer patients through its Chinese subsidiary.

·        In October 2023, Hitachi Ltd. announced the delivery of its proton therapy system to the National Cancer Center in Singapore, marking the company’s first therapy system in Southeast Asia.

·        In December 2022, IBA Worldwide signed a contract with Spain’s Ministry of Health to install 10 proton therapy systems across Spain.

About Grand View Research:

Grand View Research, Inc. is a market research and consulting company that provides off-the-shelf, customized research reports and consulting services. To help clients make informed business decisions, we offer market intelligence studies, ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials, and energy. With a deep-seated understanding of varied business environments, Grand View Research provides strategic objective insights. For more information, visit www.grandviewresearch.com

Contact:

Sherry James

Corporate Sales Specialist, USA

Grand View Research, Inc.

Phone:-1-415-349-0058

Email: [email protected]